CN102091042A - 一种单分散纳米微球药物载体的制备方法 - Google Patents
一种单分散纳米微球药物载体的制备方法 Download PDFInfo
- Publication number
- CN102091042A CN102091042A CN2011100086920A CN201110008692A CN102091042A CN 102091042 A CN102091042 A CN 102091042A CN 2011100086920 A CN2011100086920 A CN 2011100086920A CN 201110008692 A CN201110008692 A CN 201110008692A CN 102091042 A CN102091042 A CN 102091042A
- Authority
- CN
- China
- Prior art keywords
- nano microsphere
- drug carrier
- preparation
- dispersed nano
- microsphere drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title abstract description 11
- 238000000034 method Methods 0.000 title abstract description 11
- 239000002077 nanosphere Substances 0.000 title abstract 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 238000003756 stirring Methods 0.000 claims abstract description 20
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims abstract description 17
- 239000003960 organic solvent Substances 0.000 claims abstract description 13
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 11
- 238000005119 centrifugation Methods 0.000 claims abstract description 10
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 10
- 239000012153 distilled water Substances 0.000 claims abstract description 8
- 239000005457 ice water Substances 0.000 claims abstract description 8
- 238000005406 washing Methods 0.000 claims abstract description 6
- 239000004005 microsphere Substances 0.000 claims description 46
- 239000003937 drug carrier Substances 0.000 claims description 38
- 238000002360 preparation method Methods 0.000 claims description 26
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 17
- 208000035126 Facies Diseases 0.000 claims description 16
- 229930003427 Vitamin E Natural products 0.000 claims description 15
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 15
- 229940046009 vitamin E Drugs 0.000 claims description 15
- 235000019165 vitamin E Nutrition 0.000 claims description 15
- 239000011709 vitamin E Substances 0.000 claims description 15
- -1 vitamin E succinic acid ester Chemical class 0.000 claims description 14
- 229940113116 polyethylene glycol 1000 Drugs 0.000 claims description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- 239000008346 aqueous phase Substances 0.000 claims description 9
- 238000004220 aggregation Methods 0.000 claims description 7
- 230000002776 aggregation Effects 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 2
- 239000002245 particle Substances 0.000 abstract description 14
- 239000012071 phase Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000000839 emulsion Substances 0.000 abstract description 2
- 239000012074 organic phase Substances 0.000 abstract 2
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000000599 controlled substance Substances 0.000 abstract 1
- 238000000464 low-speed centrifugation Methods 0.000 abstract 1
- 239000007764 o/w emulsion Substances 0.000 abstract 1
- 238000005057 refrigeration Methods 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 238000002604 ultrasonography Methods 0.000 abstract 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 238000004945 emulsification Methods 0.000 description 3
- 229960004275 glycolic acid Drugs 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229920001002 functional polymer Polymers 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100086920A CN102091042B (zh) | 2011-01-14 | 2011-01-14 | 一种单分散纳米微球药物载体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100086920A CN102091042B (zh) | 2011-01-14 | 2011-01-14 | 一种单分散纳米微球药物载体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102091042A true CN102091042A (zh) | 2011-06-15 |
CN102091042B CN102091042B (zh) | 2013-01-09 |
Family
ID=44124423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011100086920A Active CN102091042B (zh) | 2011-01-14 | 2011-01-14 | 一种单分散纳米微球药物载体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102091042B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102728287A (zh) * | 2012-06-07 | 2012-10-17 | 东南大学 | 一种表面多孔的plga微球的制备方法 |
CN103933910A (zh) * | 2014-04-11 | 2014-07-23 | 浙江大学 | 聚合物多孔微球的制备方法 |
CN111973561A (zh) * | 2020-08-31 | 2020-11-24 | 常州药物研究所有限公司 | 去除聚合物微球溶剂中有机溶剂残留方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101697963A (zh) * | 2009-10-29 | 2010-04-28 | 福建医科大学附属协和医院 | 一种载多烯紫杉醇plga缓释微球的制备方法及其在超声介导下肿瘤间质化疗中的应用 |
-
2011
- 2011-01-14 CN CN2011100086920A patent/CN102091042B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101697963A (zh) * | 2009-10-29 | 2010-04-28 | 福建医科大学附属协和医院 | 一种载多烯紫杉醇plga缓释微球的制备方法及其在超声介导下肿瘤间质化疗中的应用 |
Non-Patent Citations (1)
Title |
---|
《中国药师》 20071231 赵亮等 维生素E琥珀酸聚乙二醇酯在紫杉醇聚酸酐微球中的应用研究 433-435 4 第10卷, 第5期 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102728287A (zh) * | 2012-06-07 | 2012-10-17 | 东南大学 | 一种表面多孔的plga微球的制备方法 |
CN102728287B (zh) * | 2012-06-07 | 2014-12-10 | 东南大学 | 一种表面多孔的plga微球的制备方法 |
CN103933910A (zh) * | 2014-04-11 | 2014-07-23 | 浙江大学 | 聚合物多孔微球的制备方法 |
CN103933910B (zh) * | 2014-04-11 | 2016-01-20 | 浙江大学 | 聚合物多孔微球的制备方法 |
CN111973561A (zh) * | 2020-08-31 | 2020-11-24 | 常州药物研究所有限公司 | 去除聚合物微球溶剂中有机溶剂残留方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102091042B (zh) | 2013-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Astete et al. | Synthesis and characterization of PLGA nanoparticles | |
JP6159787B2 (ja) | 治療用粒子の凍結乾燥に対する安定製剤 | |
Dinarvand et al. | Effect of surfactant HLB and different formulation variables on the properties of poly-D, L-lactide microspheres of naltrexone prepared by double emulsion technique | |
Morikawa et al. | The use of an efficient microfluidic mixing system for generating stabilized polymeric nanoparticles for controlled drug release | |
Li et al. | Microencapsulation by solvent evaporation: State of the art for process engineering approaches | |
Liu et al. | Diclofenac sodium-loaded solid lipid nanoparticles prepared by emulsion/solvent evaporation method | |
Ueda et al. | Optimization of the preparation of loperamide-loaded poly (L-lactide) nanoparticles by high pressure emulsification-solvent evaporation | |
Shi et al. | Photo-tunable protein release from biodegradable nanoparticles composed of cinnamic acid derivatives | |
JP5575667B2 (ja) | 薬物の投与のためのナノ粒子キャリア及びその製造方法 | |
CN101889985A (zh) | 一种载药纳米微球及其制备方法 | |
Ngwuluka et al. | Natural polymers in micro-and nanoencapsulation for therapeutic and diagnostic applications: part I: lipids and fabrication techniques | |
EP2085080A1 (en) | Preparation of nanoparticles by using a vibrating nozzle device | |
CN102091042B (zh) | 一种单分散纳米微球药物载体的制备方法 | |
Nomura et al. | Benign preparation of aqueous core poly lactic-co-glycolic acid (PLGA) microcapsules | |
Levato et al. | Preparation of biodegradable polylactide microparticles via a biocompatible procedure | |
Sawalha et al. | Preparation of hollow polylactide microcapsules through premix membrane emulsification—effects of nonsolvent properties | |
Duan et al. | Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo | |
CN103690491A (zh) | 一种peg-pla/pla复合载药纳米微球的制备方法 | |
Zhang et al. | An improvement of double emulsion technique for preparing bovine serum albumin-loaded PLGA microspheres | |
Chaw et al. | Water-soluble betamethasone-loaded poly (lactide-co-glycolide) hollow microparticles as a sustained release dosage form | |
Dinda et al. | Effect of stabilizers and process parameters for budesonide loaded PLGA-nanoparticles | |
JP2020512448A (ja) | ポリ(オキサゾリン)安定化剤を含有する有機ポリマー粒子および有機ポリマー粒子の安定化のためのポリ(オキサゾリン)の使用 | |
CN113476410A (zh) | 一种注射用曲安奈德微球植入剂及其制备方法 | |
WO2010046681A1 (en) | Nanoparticles | |
CN111514109A (zh) | 一种聚l-乳酸/聚d-乳酸-葡萄糖共聚物载药微球制备方法及产品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220207 Address after: 510098 room 3513, No. 372, Huanshi East Road, Yuexiu District, Guangzhou, Guangdong Patentee after: Guangzhou Zhikun Biotechnology Co.,Ltd. Address before: 510640 No. five, 381 mountain road, Guangzhou, Guangdong, Tianhe District Patentee before: SOUTH CHINA University OF TECHNOLOGY |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231219 Address after: Room 3513, No. 372, Huanshi East Road, Yuexiu District, Guangzhou, Guangdong, 510030 Patentee after: Guangzhou Zhiyuan Biotechnology Co.,Ltd. Address before: 510098 room 3513, No. 372, Huanshi East Road, Yuexiu District, Guangzhou, Guangdong Patentee before: Guangzhou Zhikun Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right |